{"entity":{"id":"paper-garces-hpv-indigenous-venezuela-diseases-2026","kind":"paper","name":"HPV genotypes in three Indigenous communities of Venezuela","aka":[],"tldr":"Among 260 Wayuu, Eñepa and Warao women who took their own samples, 55.4% carried HPV; the nonavalent vaccine covered a type in 69.4% of infected women, and cytology and HPV testing agreed poorly.","summary":"Published as \"Divergent Human Papillomavirus Genotype Spectra in Three Indigenous Communities of Venezuela: Implications for Vaccine Choice and Cervical Screening\". Researchers at the Universidad Central de Venezuela tested self-collected samples from women in La Guajira (Wayuu), Maniapure (Eñepa) and Delta Amacuro (Warao) with a PCR assay resolving 21 genotypes; cytology was available for 144.","asOf":"2026-11-11","links":[{"label":"Diseases 2026","url":"https://doi.org/10.3390/diseases14100384"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/42930011/"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"Diseases","year":2026,"doi":"10.3390/diseases14100384","pmid":"42930011","authors":"Garcés MF, Guzmán Silva J, Aranguren D, et al.","paperType":"observational","findings":["HPV prevalence was 55.4% and high-risk HPV 51.2%, rising from 42.6% in La Guajira to 59.6% in Maniapure and 80.0% in Delta Amacuro.","HPV-31 was the commonest type (15.8%), then HPV-16 (11.5%); half of infected women carried more than one type.","Only 20 of 78 HPV-positive women with a smear had an abnormal result.","At least one nonavalent vaccine type was present in 69.4% of infected women, against 30.6% for the bivalent vaccine."],"whatItMeans":"The authors state that HPV vaccination is not part of the Venezuelan national programme, and read their data as favouring the nonavalent vaccine and HPV-based screening with a workable triage step.","caveats":["Small samples, especially in Delta Amacuro (25 women).","Communities differ, so results may not apply to other Indigenous peoples."],"participants":260},"route":"/key-papers/paper-garces-hpv-indigenous-venezuela-diseases-2026/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"institution":[{"id":"venezuela-ministry-of-health","kind":"institution","name":"Ministerio del Poder Popular para la Salud (Venezuela)","route":"/institutions/venezuela-ministry-of-health/"}]}}